Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

Standard

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. / Rades, Dirk; Bohlen, Guenther; Dunst, Juergen; Lohynska, Radka; Veninga, Theo; Stalpers, Lukas; Schild, Steven E; Dahm-Daphi, Jochen.

In: STRAHLENTHER ONKOL, Vol. 184, No. 1, 1, 2008, p. 30-35.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rades, D, Bohlen, G, Dunst, J, Lohynska, R, Veninga, T, Stalpers, L, Schild, SE & Dahm-Daphi, J 2008, 'Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.', STRAHLENTHER ONKOL, vol. 184, no. 1, 1, pp. 30-35. <http://www.ncbi.nlm.nih.gov/pubmed/18188520?dopt=Citation>

APA

Rades, D., Bohlen, G., Dunst, J., Lohynska, R., Veninga, T., Stalpers, L., Schild, S. E., & Dahm-Daphi, J. (2008). Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. STRAHLENTHER ONKOL, 184(1), 30-35. [1]. http://www.ncbi.nlm.nih.gov/pubmed/18188520?dopt=Citation

Vancouver

Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. STRAHLENTHER ONKOL. 2008;184(1):30-35. 1.

Bibtex

@article{2cf863a19d63407c9195c8eb7174813b,
title = "Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.",
abstract = "BACKGROUND AND PURPOSE: Whole-brain radiotherapy (WBRT) is the most common treatment for brain metastases. Most of these patients have a poor survival prognosis. Therefore, a short radiation program is preferred, if it provides a similar outcome as longer programs. This study compares 20 Gy in five fractions (treatment time: 1 week) to longer programs, with higher doses including 30 Gy in ten fractions (2 weeks) and 40 Gy in 20 fractions (4 weeks). PATIENTS AND METHODS: Data regarding 1,085 patients treated with WBRT for brain metastases were retrospectively analyzed. 387 patients received 20 Gy in five fractions, and 698 patients received higher doses (30 Gy in ten fractions, n = 527, or 40 Gy in 20 fractions, n = 171). In addition, eight potential prognostic factors were investigated including age, sex, Karnofsky Performance Score (KPS), tumor type, interval from tumor diagnosis to WBRT, number of brain metastases, extracranial metastases, and recursive partitioning analysis (RPA) class. Subgroup analyses were performed for each RPA class individually. RESULTS: The WBRT schedule had no significant impact on survival (p = 0.415). On multivariate analysis, improved survival was significantly associated with age or = 70 (RR: 1.73; p = 0.002), lack of extracranial metastases (RR: 1.27; p = 0.007), interval from tumor diagnosis to WBRT > 8 months (RR: 1.19; p = 0.011), and lower RPA class (RR: 1.56; p <0.001). The subgroup analyses for each RPA class did not reveal a significant association between WBRT schedule and survival. CONCLUSION: Short-course WBRT with 20 Gy in five fractions is preferable for most patients, because it is associated with similar survival as longer programs and is less time-consuming.",
author = "Dirk Rades and Guenther Bohlen and Juergen Dunst and Radka Lohynska and Theo Veninga and Lukas Stalpers and Schild, {Steven E} and Jochen Dahm-Daphi",
year = "2008",
language = "Deutsch",
volume = "184",
pages = "30--35",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "1",

}

RIS

TY - JOUR

T1 - Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

AU - Rades, Dirk

AU - Bohlen, Guenther

AU - Dunst, Juergen

AU - Lohynska, Radka

AU - Veninga, Theo

AU - Stalpers, Lukas

AU - Schild, Steven E

AU - Dahm-Daphi, Jochen

PY - 2008

Y1 - 2008

N2 - BACKGROUND AND PURPOSE: Whole-brain radiotherapy (WBRT) is the most common treatment for brain metastases. Most of these patients have a poor survival prognosis. Therefore, a short radiation program is preferred, if it provides a similar outcome as longer programs. This study compares 20 Gy in five fractions (treatment time: 1 week) to longer programs, with higher doses including 30 Gy in ten fractions (2 weeks) and 40 Gy in 20 fractions (4 weeks). PATIENTS AND METHODS: Data regarding 1,085 patients treated with WBRT for brain metastases were retrospectively analyzed. 387 patients received 20 Gy in five fractions, and 698 patients received higher doses (30 Gy in ten fractions, n = 527, or 40 Gy in 20 fractions, n = 171). In addition, eight potential prognostic factors were investigated including age, sex, Karnofsky Performance Score (KPS), tumor type, interval from tumor diagnosis to WBRT, number of brain metastases, extracranial metastases, and recursive partitioning analysis (RPA) class. Subgroup analyses were performed for each RPA class individually. RESULTS: The WBRT schedule had no significant impact on survival (p = 0.415). On multivariate analysis, improved survival was significantly associated with age or = 70 (RR: 1.73; p = 0.002), lack of extracranial metastases (RR: 1.27; p = 0.007), interval from tumor diagnosis to WBRT > 8 months (RR: 1.19; p = 0.011), and lower RPA class (RR: 1.56; p <0.001). The subgroup analyses for each RPA class did not reveal a significant association between WBRT schedule and survival. CONCLUSION: Short-course WBRT with 20 Gy in five fractions is preferable for most patients, because it is associated with similar survival as longer programs and is less time-consuming.

AB - BACKGROUND AND PURPOSE: Whole-brain radiotherapy (WBRT) is the most common treatment for brain metastases. Most of these patients have a poor survival prognosis. Therefore, a short radiation program is preferred, if it provides a similar outcome as longer programs. This study compares 20 Gy in five fractions (treatment time: 1 week) to longer programs, with higher doses including 30 Gy in ten fractions (2 weeks) and 40 Gy in 20 fractions (4 weeks). PATIENTS AND METHODS: Data regarding 1,085 patients treated with WBRT for brain metastases were retrospectively analyzed. 387 patients received 20 Gy in five fractions, and 698 patients received higher doses (30 Gy in ten fractions, n = 527, or 40 Gy in 20 fractions, n = 171). In addition, eight potential prognostic factors were investigated including age, sex, Karnofsky Performance Score (KPS), tumor type, interval from tumor diagnosis to WBRT, number of brain metastases, extracranial metastases, and recursive partitioning analysis (RPA) class. Subgroup analyses were performed for each RPA class individually. RESULTS: The WBRT schedule had no significant impact on survival (p = 0.415). On multivariate analysis, improved survival was significantly associated with age or = 70 (RR: 1.73; p = 0.002), lack of extracranial metastases (RR: 1.27; p = 0.007), interval from tumor diagnosis to WBRT > 8 months (RR: 1.19; p = 0.011), and lower RPA class (RR: 1.56; p <0.001). The subgroup analyses for each RPA class did not reveal a significant association between WBRT schedule and survival. CONCLUSION: Short-course WBRT with 20 Gy in five fractions is preferable for most patients, because it is associated with similar survival as longer programs and is less time-consuming.

M3 - SCORING: Zeitschriftenaufsatz

VL - 184

SP - 30

EP - 35

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 1

M1 - 1

ER -